267 related articles for article (PubMed ID: 24112791)
1. Effects of the neurotrophic agent T-817MA on oligomeric amyloid-β-induced deficits in long-term potentiation in the hippocampal CA1 subfield.
Takamura Y; Ono K; Matsumoto J; Yamada M; Nishijo H
Neurobiol Aging; 2014 Mar; 35(3):532-6. PubMed ID: 24112791
[TBL] [Abstract][Full Text] [Related]
2. A novel neurotrophic agent, T-817MA [1-{3-[2-(1-benzothiophen-5-yl) ethoxy] propyl}-3-azetidinol maleate], attenuates amyloid-beta-induced neurotoxicity and promotes neurite outgrowth in rat cultured central nervous system neurons.
Hirata K; Yamaguchi H; Takamura Y; Takagi A; Fukushima T; Iwakami N; Saitoh A; Nakagawa M; Yamada T
J Pharmacol Exp Ther; 2005 Jul; 314(1):252-9. PubMed ID: 15798005
[TBL] [Abstract][Full Text] [Related]
3. Ameliorative effects of a neuroprotective agent, T-817MA, on place learning deficits induced by continuous infusion of amyloid-beta peptide (1-40) in rats.
Nguyen PT; Kimura T; Ho SA; Tran AH; Ono T; Nishijo H
Hippocampus; 2007; 17(6):443-55. PubMed ID: 17397046
[TBL] [Abstract][Full Text] [Related]
4. A neuroprotective agent, T-817MA (1-{3-[2-(1-benzothiophen-5-yl)ethoxy]propyl} azetidin-3-ol maleate), prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice.
Kawasaki T; Ago Y; Kitao T; Nashida T; Takagi A; Takuma K; Matsuda T
Neuropharmacology; 2008 Oct; 55(5):654-60. PubMed ID: 18573265
[TBL] [Abstract][Full Text] [Related]
5. T-817MA, a neurotrophic agent, ameliorates the deficits in adult neurogenesis and spatial memory in rats infused i.c.v. with amyloid-beta peptide.
Kimura T; Hong Nguyen PT; Ho SA; Tran AH; Ono T; Nishijo H
Br J Pharmacol; 2009 Jun; 157(3):451-63. PubMed ID: 19371351
[TBL] [Abstract][Full Text] [Related]
6. T-817MA, a neuroprotective agent, attenuates the motor and cognitive impairments associated with neuronal degeneration in P301L tau transgenic mice.
Fukushima T; Nakamura A; Iwakami N; Nakada Y; Hattori H; Hoki S; Yamaguchi H; Nakagawa M; Terashima N; Narita H
Biochem Biophys Res Commun; 2011 Apr; 407(4):730-4. PubMed ID: 21439944
[TBL] [Abstract][Full Text] [Related]
7. Impairment of Spike-Timing-Dependent Plasticity at Schaffer Collateral-CA1 Synapses in Adult APP/PS1 Mice Depends on Proximity of Aβ Plaques.
Garad M; Edelmann E; Leßmann V
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573114
[TBL] [Abstract][Full Text] [Related]
8. [Chronic effects of oligomeric Aβ(1-42) on hippocampal synaptic plasticity in vivo].
Tan T; Zhang BL; Tian X
Sheng Li Xue Bao; 2011 Jun; 63(3):225-32. PubMed ID: 21681340
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacological properties of T-817MA, a novel neurotrophic agent, for treatment of Alzheimer's disease.].
Fukushima T
Nihon Yakurigaku Zasshi; 2010 Jul; 136(1):11-4. PubMed ID: 20628207
[No Abstract] [Full Text] [Related]
10. T-817MA, a novel neurotrophic agent, improves sodium nitroprusside-induced mitochondrial dysfunction in cortical neurons.
Fukushima T; Koide M; Ago Y; Baba A; Matsuda T
Neurochem Int; 2006 Jan; 48(2):124-30. PubMed ID: 16219389
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effects of T-817MA against noise-induced hearing loss.
Yamashita D; Shiotani A; Kanzaki S; Nakagawa M; Ogawa K
Neurosci Res; 2008 May; 61(1):38-42. PubMed ID: 18343519
[TBL] [Abstract][Full Text] [Related]
12. T-817MA, a novel neurotrophic agent, ameliorates loss of GABAergic parvalbumin-positive neurons and sensorimotor gating deficits in rats transiently exposed to MK-801 in the neonatal period.
Uehara T; Sumiyoshi T; Hattori H; Itoh H; Matsuoka T; Iwakami N; Suzuki M; Kurachi M
J Psychiatr Res; 2012 May; 46(5):622-9. PubMed ID: 22342346
[TBL] [Abstract][Full Text] [Related]
13. In vivo injected mitochondria-targeted plastoquinone antioxidant SkQR1 prevents β-amyloid-induced decay of long-term potentiation in rat hippocampal slices.
Kapay NA; Isaev NK; Stelmashook EV; Popova OV; Zorov DB; Skrebitsky VG; Skulachev VP
Biochemistry (Mosc); 2011 Dec; 76(12):1367-70. PubMed ID: 22150282
[TBL] [Abstract][Full Text] [Related]
14. MRZ-99030 - A novel modulator of Aβ aggregation: II - Reversal of Aβ oligomer-induced deficits in long-term potentiation (LTP) and cognitive performance in rats and mice.
Rammes G; Gravius A; Ruitenberg M; Wegener N; Chambon C; Sroka-Saidi K; Jeggo R; Staniaszek L; Spanswick D; O'Hare E; Palmer P; Kim EM; Bywalez W; Egger V; Parsons CG
Neuropharmacology; 2015 May; 92():170-82. PubMed ID: 25637092
[TBL] [Abstract][Full Text] [Related]
15. Dysregulated CRTC1-BDNF signaling pathway in the hippocampus contributes to Aβ oligomer-induced long-term synaptic plasticity and memory impairment.
Yan P; Xue Z; Li D; Ni S; Wang C; Jin X; Zhou D; Li X; Zhao X; Chen X; Cui W; Xu D; Zhou W; Zhang J
Exp Neurol; 2021 Nov; 345():113812. PubMed ID: 34274327
[TBL] [Abstract][Full Text] [Related]
16. D-Ala2GIP facilitated synaptic plasticity and reduces plaque load in aged wild type mice and in an Alzheimer's disease mouse model.
Faivre E; Hölscher C
J Alzheimers Dis; 2013; 35(2):267-83. PubMed ID: 23568101
[TBL] [Abstract][Full Text] [Related]
17. Chronic nicotine restores normal Aβ levels and prevents short-term memory and E-LTP impairment in Aβ rat model of Alzheimer's disease.
Srivareerat M; Tran TT; Salim S; Aleisa AM; Alkadhi KA
Neurobiol Aging; 2011 May; 32(5):834-44. PubMed ID: 19464074
[TBL] [Abstract][Full Text] [Related]
18. Cocoa extracts reduce oligomerization of amyloid-β: implications for cognitive improvement in Alzheimer's disease.
Wang J; Varghese M; Ono K; Yamada M; Levine S; Tzavaras N; Gong B; Hurst WJ; Blitzer RD; Pasinetti GM
J Alzheimers Dis; 2014; 41(2):643-50. PubMed ID: 24957018
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the Effect of Exercise on Late-Phase LTP of the Dentate Gyrus and CA1 of Alzheimer's Disease Model.
Dao AT; Zagaar MA; Levine AT; Alkadhi KA
Mol Neurobiol; 2016 Dec; 53(10):6859-6868. PubMed ID: 26660327
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin improves synaptic plasticity and memory deficits by decrease of the neurotransmitter release probability in the rat model of Alzheimer's disease.
Esmaeili Tazangi P; Moosavi SM; Shabani M; Haghani M
Pharmacol Biochem Behav; 2015 Mar; 130():15-21. PubMed ID: 25553822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
